About 1,053 results

ALLMedicine™ Juvenile Myoclonic Epilepsy Center

Research & Reviews  248 results

ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by...
Epilepsia Hirsch E, French J et. al.

May 4th, 2022 - In 2017, the International League Against Epilepsy (ILAE) Classification of Epilepsies described the "genetic generalized epilepsies" (GGEs), which contained the "idiopathic generalized epilepsies" (IGEs). The goal of this paper is to delineate th...

Aberrant dynamic structure-function relationship of rich-club organization in treatment...
Human Brain Mapping; Liu G, Zheng W et. al.

Apr 14th, 2022 - Neuroimaging studies have shown that juvenile myoclonic epilepsy (JME) is characterized by impaired brain networks. However, few studies have investigated the potential disruptions in rich-club organization-a core feature of the brain networks. Mo...

Seizure and social outcomes in patients with juvenile myoclonic epilepsy (JME).
Seizure Asadi-Pooya AA, Rostamihosseinkhani M et. al.

Mar 9th, 2022 - To investigate the seizure outcome in patients with juvenile myoclonic epilepsy (JME) and its associated factors. We also investigated the social outcome of these patients. This was a retrospective study. All patients with a diagnosis of JME were ...

Generalized Epilepsies on EEG

Mar 7th, 2022 - Overview The International Classification of Epileptic Syndromes and Epilepsies [1] classifies the epilepsies along 2 dichotomies: (1) partial (ie, focal, localization-related) versus generalized and (2) genetic (idiopathic) versus unknown or symp...

Generalized Epilepsies on EEG

Mar 7th, 2022 - The International Classification of Epileptic Syndromes and Epilepsies[1] classifies the epilepsies along 2 dichotomies: (1) partial (ie, focal, localization-related) versus generalized and (2) genetic (idiopathic) versus unknown or symptomatic. T...

see more →

Guidelines  2 results

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic d...
Neurology Kanner AM, Ashman E et. al.

Jun 15th, 2018 - To update the 2004 American Academy of Neurology (AAN) guideline for treating new-onset focal or generalized epilepsy with second- and third-generation antiepileptic drugs (AEDs). The 2004 AAN criteria were used to systematically review literature...

Guidelines for imaging infants and children with recent-onset epilepsy.
Epilepsia Gaillard WD, Chiron C et. al.

Apr 25th, 2009 - The International League Against Epilepsy (ILAE) Subcommittee for Pediatric Neuroimaging examined the usefulness of, and indications for, neuroimaging in the evaluation of children with newly diagnosed epilepsy. The retrospective and prospective p...

see more →

Drugs  160 results see all →

News  11 results

Levetiracetam Oral Solution Recalled in US

Dec 20th, 2019 - Lannett Company Inc has voluntarily recalled two lots of levetiracetam oral solution (100 mg/mL) to the consumer level because of contamination with Bacillus subtilis, which was identified during an evaluation of a raw material used to manufacture...

Hippocampal abnormalities seen in epilepsy subtypes may be congenital
Michele G. Sullivan

Dec 20th, 2018 - NEW ORLEANS – Abnormalities of hippocampal volume and morphology in children with temporal lobe or juvenile myoclonic epilepsy (JME) are also present in the brains of their unaffected siblings, although to a lesser extent, based on findings from t.

Unique MRI Findings in Juvenile Myoclonic Epilepsy

Oct 24th, 2018 - The cortical regions of the brains of patients with juvenile myoclonic epilepsy (JME) are more likely to be disassociated from subcortical structures, according to a recent study that compared the MRI readings of JME patients to those of normal ch.

Variants in one gene account for 7% of juvenile myoclonic epilepsy cases
Michele G. Sullivan

Mar 14th, 2018 - An extremely rare genetic variant that affects the maturation, migration, and death of neurons appears to be responsible for about 7% of cases of juvenile myoclonic epilepsy. Variants of the intestinal-cell kinase gene (ICK) occurred in 12 members.

Lannett Issues Voluntary Nationwide Recall of Levetiracetam Oral Solution, 100mg/Ml Due to Microbial Contamination

Summary Company Announcement Date: December 18, 2019 FDA Publish Date: December 18, 2019 Product Type: Drugs Reason for Announcement: Recall Reason Description Bacillus subtilis Company Name: Lannett Company, Inc. Brand Name: Brand Name(s) Lannett...

see more →